Details for New Drug Application (NDA): 020616
✉ Email this page to a colleague
The generic ingredient in KADIAN is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Summary for 020616
Tradename: | KADIAN |
Applicant: | Allergan |
Ingredient: | morphine sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020616
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 20MG | ||||
Approval Date: | Jul 3, 1996 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 50MG | ||||
Approval Date: | Jul 3, 1996 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Jul 3, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 020616
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | KADIAN | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 020616-002 | Jul 3, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | KADIAN | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 020616-007 | Feb 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | KADIAN | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 020616-006 | Oct 27, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | KADIAN | morphine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 020616-008 | Apr 20, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription